Decoding Skin Aging: L’Oréal and NUS Medicine Launch Joint Lab
Beauty science is taking a giant leap forward. L’Oréal Groupe and the NUS Academy for Healthy Longevity at NUS Medicine (National University of Singapore) officially announced on August 11, 2026, a multi-year strategic research partnership. This collaboration also marks the opening of a new joint laboratory dedicated to understanding what skin, scalp, and hair reveal about systemic aging.
Located at the Healthy Longevity Clinical Trial Centre on the NUS Medicine campus in Singapore, the lab will integrate L’Oréal’s advanced skin evaluation tools directly into NUS Medicine’s clinical longevity trials. The research will encompass a comprehensive battery of measures, including:
- Cardiovascular health
- Metabolic health
- Cognitive health
- Musculoskeletal health
These measures will be assessed alongside detailed skin evaluations, to determine whether skin aging can serve as a reliable, non-invasive indicator of systemic biological aging.
L’Oréal, which invests €1.3 billion annually in research and innovation across 22 global research centers, said findings will feed into its Longevity Integrative Science™ framework. The ultimate goal is to shift skincare from a purely cosmetic discipline to one that plays an active role in preventative health and personalized anti-aging medicine.
“If signs in the skin turn out to be meaningful indicators about how the whole body is ageing, that changes what a skin measurement really tells us,” said Dr. Angeline Tay, Head of Advanced Research at L’Oréal Research & Innovation in Singapore.